Merck KGaA
MKGAF
$136.74
-$5.67-3.98%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.25% | 7.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.25% | 7.34% | |||
| Cost of Revenue | -2.67% | 12.55% | |||
| Gross Profit | 9.34% | 3.80% | |||
| SG&A Expenses | 1.90% | 8.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -208.97% | 8.75% | |||
| Total Operating Expenses | -3.29% | 10.14% | |||
| Operating Income | 41.16% | -4.58% | |||
| Income Before Tax | 39.54% | -6.48% | |||
| Income Tax Expenses | 33.21% | -13.92% | |||
| Earnings from Continuing Operations | 41.23% | -4.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 237.35% | -7.85% | |||
| Net Income | 42.51% | -4.33% | |||
| EBIT | 41.16% | -4.58% | |||
| EBITDA | 30.53% | -3.45% | |||
| EPS Basic | 42.16% | -4.28% | |||
| Normalized Basic EPS | 40.81% | -6.50% | |||
| EPS Diluted | 42.16% | -4.28% | |||
| Normalized Diluted EPS | 40.81% | -6.50% | |||
| Average Basic Shares Outstanding | 0.25% | -0.06% | |||
| Average Diluted Shares Outstanding | 0.25% | -0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | 23.34% | |||